IGF2BP3 and acute myeloid leukemia: We found that insulin growth factor 2 mRNA binding protein 3 (IGF2BP3) increases the stability of methylation by recognizing and binding m6A-modified mRNA of erythropoietin receptor (EPOR), thereby activating JAK/STAT signaling pathway to promote AML progression.